US 9937222
Modulators of complement activity
granted A61KA61K38/10A61K39/00
Quick answer
US patent 9937222 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/10, A61K39/00, A61P, A61P25/00